PulseMedica

PulseMedica is a Canadian health tech startup committed to revolutionizing vitreo retinal treatments. Their proprietary real-time 3D imaging and laser targeting system, along with their patented next-generation ultrafast femtosecond laser ophthalmic treatment, provides precise and effective solutions for retinal diseases, including age-related macular degeneration (AMD) and glaucoma. Established in 2018, the company received a seed round investment from UCeed on 12 April 2023. PulseMedica's dedication to advancing retinal care makes them a promising prospect for investors seeking opportunities in the health care industry. With their headquarters located in Edmonton, AB, Canada, they are well-positioned to drive innovation and address critical unmet medical needs.